Abstract
The nervous system is commonly impacted by chemicals found in nature, elaborated by organisms, or synthesized by chemists. The peculiar architecture of neural cells, their high-energy demands, and the mandate for electrochemical communication combine to place the nervous system at high risk for chemical perturbation. This inherent vulnerability is exploited by natural agents, synthetic chemicals, medications, and recreational substances designed or used to target the nervous system as well as by a host of other substances that are occasionally encountered in the environment. The neurotoxic actions of chemicals are expressed in a wide range of neurologic phenomena, some of which are associated with purely functional changes, others with structural damage, and still others with both. Many chemicals cause effects that appear and disappear rapidly; others produce effects that evolve over days or weeks and regress over months or years. Diagnosis is heavily dependent on the history and characteristic clinical phenomenology. Specific treatment other than termination of exposure is rare. Although clinical improvement is the rule, neurotoxic disorders leave scars or disappear without a trace.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Price DL, Griffin JW: Neurons and Ensheathing Cells as Targets of Disease Processes. In Experimental and Clinical Neurotoxicology. Edited by Spencer PS, Schaumburg HH. Baltimore: Williams & Wilkins; 1980: 2–23.
Toro-Gonzalez G, Roman-Campos G, de Roman LN: Neurologia Tropical: Aspectos Neuropatologicos de la Medicina Tropical. Bogota: Colombiana, Ltd.; 1983.
Vinken PJ, Bruyn GW: Handbook of Clinical Neurology, vol 36. Intoxications of the Nervous System, part I. Amsterdam: North-Holland Publishing; 1979.
Rosling H: Cassava Toxicity and Food Security, edn 2 Uppsala, Sweden: Tryck Kontact; 1988.
Halstead BW: Poisonous and Venomous Marine Animals of the World, edn 2. Princeton: Darwin Press; 1988.
Anon: Toxic Fish and Mollusks. Air Training Command of Maxwell Air Force Base, Alabama, Information Bulletin No. 12, US Government Printing Office, Washington, DC, Stock No. 008–070–00426–7, Class No. D301.38/8:12; June 1979.
Vinken PJ, Bruyn GW: Handbook of Clinical Neurology, vol 37. Intoxications of the Nervous System, part II. New York: North-Holland Publishing; 1979.
Anon: Venomous Arthropod Handbook. USAF School of Aerospace Medicine, Brooks Air Force Base, Texas 78235, US Government Printing Office, Washington, DC, Stock No. 008–070–00397–0, Catalog No. D 301.35: 161/43; 1977.
Saida K, Mendell JR, Sahenk Z: Peripheral nerve changes induced by local application of bee venom. J Neuropathol Exp Neurol 1977, 36: 783–796.
Villee CA, Solomon EP, Martin CE, et al.: Biology, edn 2. Philadelphia: WB Saunders; 1989.
Tu AT: Handbook of Natural Toxins: vol 3. Marine Toxins and Venoms. New York: Marcel Dekker; 1988.
Clarren SK: Recognition of fetal alcohol syndrome. JAM’A 1981, 245: 2436–2439.
Victor M, Adams RD, Mancall EL: A restricted form of cerebellar cortical degeneration occurring in alcoholic patients. AMAArch Neurol 1959, 1: 579–688.
Lieber CS: Medical and Nutritional Complications of Alcoholism. New York: Plenum; 1992.
Rosenberg NL, Kleinschmidt-DeMasters BK, Davis KA, et al.: Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 1988, 23:611–614.
Schneider JS, Gupta M: Current Conceptsin Parkinson’s Disease Research. Seattle: Hogrefe & Huber, 1993.
Calne DB, Chu NS, Huang C-C, et al.: Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994, 44:1583–1586.
Mena I, Court J, Fuenzalida S, et al.: Modification of chronic manganese poisoning: Treatment with L-dopa or 5-OH tryptophane. N Engl J Med 1970, 282:5–10.
Spillane JD: Tropical Neurology. London: Oxford University Press; 1973.
Kandel ER, Schwartz JH, Jessell TM: Principles of Neural Science, edn 3. Norwalk, CT: Appleton & Lange; 1991.
Kisby GE, Ellison M, Spencer PS: Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methyl-Lalanine) in cycad flour prepared by Guam Chamorros. Neurology 1992, 42: 1336–1340.
Zhang ZX, Anderson DW, Mantel N, Roman GC: Motor neuron disease on Guam: geographic and familial occurence 1956–85. Acta Neurol Scand 1996, 94: 51–59.
Tellez I, Cabello A, Franch O, et al.: Chromatolytic changes in the central nervous system of patients with the toxic oil syndrome. Acta Neuropathol (Berlin) 1987, 74:354–361.
Spillane JD: An Atlas of Clinical Neurology. London: Oxford; 1968.
Chapon F, Lechevalier B, Da Silva DC, et al.: Neuropathies la thalidomide. Rev Neurol (Paris) 1985, 141:719–728.
Alderson K, Holds JB, Anderson RL: Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 1991, 41: 1800–1805.
Sanborn GE, Selhorst JB, Calabrese VP, Taylor JR: Pseudomotor cerebri and insecticide intoxication. Neurology 1979, 29: 1222–1227.
Majoos FL, Marais AD, Ames FR: Thallium poisoning. SAfr Med J 1983, 64: 328–330.
Poirier RH: The Corneal Limbus. In Corneal Disorders: Clinical Diagnosis and Management. Edited by Leibowitz HM. Philadelphia: WB Saunders; 1984: 185–211.
Towfighi J, Gonatas NK, McCree L: Hexachlorophene-induced changes in central and peripheral myelinated axons of developing and adult rats. Lab Invest 1975, 31: 712–721.
Towfighi J, Gonatas NK, McCree L: Hexachlorophene neuropathy in rats. Lab Invest 1973, 29: 428–436.
Schaumburg HH, Berger AR, Thomas PK: Disorders of Peripheral Nerves, edn 2. Philadelphia: FA Davis; 1992.
Schaumburg HH, Spencer PS: Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study. Brain 1976, 99: 183–192.
Gold BG: The pathophysiology of proximal neurofilamentous giant axonal swellings: implications for the pathogenesis of amyotrophic lateral sclerosis. Toxicology 1987, 46: 125–139.
Gold BG, Lowndes HE: Electrophysiological investigation of 3, 3’iminodipropionitrile neuropathy: intracellular recordings in spinal cord. Brain Res 1984, 308: 235–244.
Spencer PS, Sterman AB, Horoupian D, Bischoff M: Neurotoxic changes in rats exposed to the fragrance compound acetyl ethyl tetramethyl tetralin. Neurotoxicology 1979, 1: 221–237.
Spencer PS, Sterman AB, Horoupian DS, Foulds MM: Neurotoxic fragrance produces ceroid and myelin disease. Science 1979, 204: 633–635.
Spencer PS, Schaumberg HH, Ludolph AC: Experimental and Clinical Neurotoxicology, edn. 2 New York: Oxford University Press; 2000.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gold, B.G., Schnell, J.V., Spencer, P.S. (2003). Neurotoxic Disorders. In: Rosenberg, R.N. (eds) Atlas of Clinical Neurology. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-4552-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4552-8_14
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-4757-4554-2
Online ISBN: 978-1-4757-4552-8
eBook Packages: Springer Book Archive